Metagenomi Therapeutics (MGX) Return on Equity [ROE] (2024 - 2026)
Metagenomi Therapeutics (MGX) posted Return on Equity [ROE] of -74.66% for Q2 2026, down 32.01 percentage points from -42.65% a year earlier and down 16.71 percentage points from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For FY2025, Metagenomi Therapeutics' Return on Equity [ROE] came in at -44.67%, up 112.59 percentage points from FY2024.
- In prior years, Metagenomi Therapeutics' Return on Equity [ROE] was -157.26% in FY2024.
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -5.72 percentage points over the last six quarters.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -57.96% (Q1 2026), -52.14% (Q4 2025) and -47.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Metagenomi Therapeutics | 38.53 Mn | 38.53 Mn | - | -74.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -74.66% |
| Mar 31, 2026 | -57.96% |
| Dec 31, 2025 | -52.14% |
| Sep 30, 2025 | -47.42% |
| Jun 30, 2025 | -42.65% |
| Mar 31, 2025 | -34.84% |
| Dec 31, 2024 | -31.82% |
| Sep 30, 2024 | -28.16% |
| Jun 30, 2024 | -27.52% |
| Mar 31, 2024 | -110.35% |
API Access
Metagenomi Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();